Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE study.

"Declarations Conflict of interestAR, KB, IO, CD, JS, PRT, MF, JK, SB, UG, GT, AG, JR, AL, HP, PK declare no competing interests. HV is Chief Science Officer of GlycoCheck BV, The Netherlands. Ethical approvalThe study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the General Medical Council Westfalen-Lippe and the WWU Münster, Germany (File Number: amendments of 2016-073-f-S). Informed consentPatients were enrolled upon after obtaining written informed consent from them or their legal representatives. Conflict of interest AR, KB, IO, CD, JS, PRT, MF, JK, SB, UG, GT, AG, JR, AL, HP, PK declare no competing interests. HV is Chief Science Officer of GlycoCheck BV, The Netherlands."

"Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported by the Innovative Medical Research Fund of the University of Münster Medical School (I-RO221907, to AR and KB), and by the German Research Foundation (rotational position of KFO 342 – ZA428/18-1 to AR and CD; KU 2873/3-1 to PK, RO 4537/5-1 to JR and LU-2321/1-1 to AL). The funding sources had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript."